prikaz prve stranice dokumenta Hiperparatireoidizam nakon transplantacije bubrega
  Download
PDF 4.34 MB
Scientific paper - Review paper
Hiperparatireoidizam nakon transplantacije bubrega
Medicina Fluminensis : Medicina Fluminensis, 60 (2024), 2; 176-183. https://doi.org/10.21860/medflum2024_316225
Orlić, Lidija

Cite this document

Orlić, L. (2024). Hiperparatireoidizam nakon transplantacije bubrega. Medicina Fluminensis : Medicina Fluminensis, 60. (2), 176-183. doi: 10.21860/medflum2024_316225

Orlić, Lidija. "Hiperparatireoidizam nakon transplantacije bubrega." Medicina Fluminensis : Medicina Fluminensis, vol. 60, no. 2, 2024, pp. 176-183. https://doi.org/10.21860/medflum2024_316225

Orlić, Lidija. "Hiperparatireoidizam nakon transplantacije bubrega." Medicina Fluminensis : Medicina Fluminensis 60, no. 2 (2024): 176-183. https://doi.org/10.21860/medflum2024_316225

Orlić, L. (2024) 'Hiperparatireoidizam nakon transplantacije bubrega', Medicina Fluminensis : Medicina Fluminensis, 60(2), pp. 176-183. doi: 10.21860/medflum2024_316225

Orlić L. Hiperparatireoidizam nakon transplantacije bubrega. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2024 June 01 [cited 2024 December 13];60(2):176-183. doi: 10.21860/medflum2024_316225

L. Orlić, "Hiperparatireoidizam nakon transplantacije bubrega", Medicina Fluminensis : Medicina Fluminensis, vol. 60, no. 2, pp. 176-183, June 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:723031. [Accessed: 13 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (croatian)Hiperparatireoidizam nakon transplantacije bubrega
Title (english)Hyperparathyreoidism After Kidney Transplantation
AuthorLidija Orlić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (croatian)
Nakon uspješne transplantacije bubrega dolazi do oporavka egzokrine i endokrine funkcije bubrega. Vrijednosti serumske koncentracije kalcija, fosfata, paraireoidnog hormona (PTH), čimbenika rasta fibroblasta 23 i vitamina D se normaliziraju. Zbog toga bi trebale uslijediti pozitivne promjene u koštanom metabolizmu. Kod dijela bolesnika, unatoč uspješnoj transplantaciji, ostaju poremećaji u koštanom metabolizmu. Učestalost hiperparatireoidizma (HPT) nakon prve godine od transplantacije bubrega kreće se od 10 do 50 %. Trajanje dijalize i stupanj hiperplazije paratireoidnih žlijezda čimbenici su rizika za razvoj poslijetransplantacijskog HPT-a. Liječenje poslijetransplantacijskog HPT-a uključuje terapiju vitaminom D, analozima vitamina D, kalcimemeticima i paratireidektomija.
Abstract (english)
After successful kidney transplantation, the recovery of exocrine and endocrine kidney function occurs. Serum calcium, parathyroid hormone (PTH) phosphate, fibroblast growth factor 23 (FGF-23) and vitamin D values normalize. Therefore, positive changes in bone metabolism improve bone quality, reducing the frequency of fractures and vascular calcifications. In some patients, despite successful transplantation, disorders in bone metabolism remain. The incidence of hyperparathyroidism (HPT) after the first year of kidney transplantation ranges from 10-50%. The duration of dialysis and the degree of hyperplasia of the parathyroid glands are risk factors for the development of posttransplant HPT. The treatment of posttransplant HPT includes vitamin D therapy, vitamin D analogs, calcimimetics and parathyroidectomy (PTX).
Keywords (croatian)
Keywords (english)
Languagecroatian
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina Fluminensis : Medicina Fluminensis
Numberingvol. 60, no. 2, pp. 176-183
p-ISSN1847-6864
e-ISSN1848-820X
DOIhttps://doi.org/10.21860/medflum2024_316225
URN:NBNurn:nbn:hr:184:723031
Publication2024-06-01
Document URLhttps://hrcak.srce.hr/316225
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2024-06-06 07:36:23